Hypertension, elevated cholesterol and hearing difficulty are more prevalent among noise‐exposed workers, according to new research led by the Centers for Disease Control and Prevention (CDC)’s National Institute for Occupational Safety and Health (NIOSH).

Amid ongoing controversies involving misuse of information about its users, Facebook has shelved plans to share user data with several major U.S. hospitals. CNBC reported the social media giant had scientists approach organizations, including the American College of Cardiology, about the project.

Though many areas of the world are seeing an increase in childhood obesity rates, Amsterdam has cut the number of overweight and obese children by 12 percent through city-wide “healthy-weight program" that has kids weighed regularly and tested for balance and agility.

Both men and women over the age of 50 have reduced their risk factors for heart disease and stroke over a 20-year period, according to a new study published online March 22 in Aging Clinical and Experimental Research.

Individuals who consume large amounts of meat protein experience a 60 percent increase in cardiovascular disease (CVD), according to research published in the International Journal of Epidemiology on April 3.

Transcatheter aortic valve replacement (TAVR) was associated with lower in-hospital mortality and significantly fewer respiratory complications than surgery for patients with chronic obstructive pulmonary disease (COPD), according to study published April 1 in the Journal of the American Heart Association.

According to a new study in JAMA, people who lost at least 75 percent of their net worth in a two-year period showed a 50 percent increased risk of dying over two decades compared to those who maintained positive wealth.

Outcomes-based pricing agreements would do little to help the poor cost-effectiveness of PCSK9 inhibitors. The event rates in preventive medicine are simply too low and medication costs too high for such a compromise to make a difference, a group from University of California, San Francisco reported in the Annals of Internal Medicine.

Already approved for the purpose its name implies, the Gore Cardioform septal occluder has also received the FDA’s OK for patent foramen ovale (PFO) closure to prevent recurrent ischemic stroke.

A genetic test to inform decisions about what antiplatelet to use following percutaneous coronary intervention (PCI) significantly reduced the number of major cardiovascular or cerebrovascular events in a single-center study published in Circulation: Genomic and Precision Medicine.